Investing
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors...
Hi, what are you looking for?
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors...
John Feneck, portfolio manager and consultant at Feneck Consulting, shares his outlook for gold and silver prices and stocks. He also speaks ‘special situation’...
Steve Penny, founder of SilverChartist.com, explains why he currently has a bullish outlook for gold, silver and platinum, as well as uranium. “The reaction...
The following is a list of Upcoming Meeting Dates for Reporting Issuers in Canada. The data is supplied by Issuing Companies through the service...
Here’s a quick recap of the crypto landscape for Friday (November 7) as of 9:00 p.m. UTC. Get the latest insights on Bitcoin, Ether...
(TheNewswire) Vancouver, British Columbia TheNewswire – November 10, 2025 Juggernaut Exploration Ltd (JUGR.V) (OTCPK: JUGRF) (FSE: 4JE) ( the ‘Company’ or ‘Juggernaut’) is excited...
Plus, we break down next week’s market catalysts to watch to help you prepare for the week ahead. In this article: This week’s tech...
Lobo Tiggre, CEO of IndependentSpeculator.com, shares why copper is his highest-confidence trade for 2026, as well as when he will consider buying. ‘I now...
Statistics Canada released October’s job numbers on Friday (November 7). The data showed a surprise expansion of the Canadian labor market with the addition...
Rich Checkan, president and COO of Asset Strategies International, shares his thoughts on the recent pullback in gold and silver prices, emphasizing that both...